| Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases BE Oftedal, A Hellesen, MM Erichsen, E Bratland, A Vardi, J Perheentupa, ... Immunity 42 (6), 1185-1196, 2015 | 258 | 2015 |
| Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease C Dölle, I Flønes, GS Nido, H Miletic, N Osuagwu, S Kristoffersen, ... Nature communications 7 (1), 13548, 2016 | 249 | 2016 |
| Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia MJ Farrer, JT Stone, CH Lin, JC Dächsel, MM Hulihan, K Haugarvoll, ... Parkinsonism & related disorders 13 (2), 89-92, 2007 | 225 | 2007 |
| Lrrk2 R1441C parkinsonism is clinically similar to sporadic Parkinson disease K Haugarvoll, R Rademakers, JM Kachergus, K Nuytemans, OA Ross, ... Neurology 70 (16_part_2), 1456-1460, 2008 | 176 | 2008 |
| Novel pathogenic LRRK2 p. Asn1437His substitution in familial Parkinson's disease JO Aasly, C Vilariño‐Güell, JC Dachsel, PJ Webber, AB West, ... Movement disorders 25 (13), 2156-2163, 2010 | 158 | 2010 |
| The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease B Brakedal, C Dölle, F Riemer, Y Ma, GS Nido, GO Skeie, AR Craven, ... Cell metabolism 34 (3), 396-407. e6, 2022 | 148 | 2022 |
| α-Synuclein and Parkinson disease susceptibility S Winkler, J Hagenah, S Lincoln, M Heckman, K Haugarvoll, ... Neurology 69 (18), 1745-1750, 2007 | 146 | 2007 |
| Neuronal complex I deficiency occurs throughout the Parkinson’s disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage IH Flønes, E Fernandez-Vizarra, M Lykouri, B Brakedal, GO Skeie, ... Acta neuropathologica 135, 409-425, 2018 | 105 | 2018 |
| Glitazone use associated with reduced risk of Parkinson's disease B Brakedal, I Flønes, SF Reiter, Ø Torkildsen, C Dölle, J Assmus, ... Movement Disorders 32 (11), 1594-1599, 2017 | 97 | 2017 |
| Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations C Tzoulis, GT Tran, T Schwarzlmüller, K Specht, K Haugarvoll, N Balafkan, ... Brain 136 (8), 2393-2404, 2013 | 89 | 2013 |
| Clinical features of LRRK2 parkinsonism K Haugarvoll, ZK Wszolek Parkinsonism & related disorders 15, S205-S208, 2009 | 74 | 2009 |
| The influence of cerebrovascular risk factors on incident dementia in patients with Parkinson's disease K Haugarvoll, D Aarsland, T Wentzel‐Larsen, JP Larsen Acta neurologica scandinavica 112 (6), 386-390, 2005 | 72 | 2005 |
| Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson’s disease brain L Toker, GT Tran, J Sundaresan, OB Tysnes, G Alves, K Haugarvoll, ... Molecular neurodegeneration 16, 1-20, 2021 | 67 | 2021 |
| Genomewide association, Parkinson disease, and PARK10 MJ Farrer, K Haugarvoll, OA Ross, JT Stone, NM Milkovic, SA Cobb, ... The American Journal of Human Genetics 78 (6), 1084-1088, 2006 | 66 | 2006 |
| FGF20 and Parkinson's disease: No evidence of association or pathogenicity via α‐synuclein expression C Wider, JC Dachsel, AI Soto, MG Heckman, NN Diehl, M Yue, S Lincoln, ... Movement disorders 24 (3), 455-459, 2009 | 60 | 2009 |
| Ultradeep mapping of neuronal mitochondrial deletions in Parkinson's disease GS Nido, C Dölle, I Flønes, HA Tuppen, G Alves, OB Tysnes, K Haugarvoll, ... Neurobiology of aging 63, 120-127, 2018 | 58 | 2018 |
| MRI characterisation of adult onset alpha-methylacyl-coA racemase deficiency diagnosed by exome sequencing K Haugarvoll, S Johansson, C Tzoulis, BI Haukanes, C Bredrup, ... Orphanet journal of rare diseases 8, 1-10, 2013 | 58 | 2013 |
| Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis C Sundal, M Baker, V Karrenbauer, M Gustavsen, S Bedri, A Glaser, ... European Journal of Neurology 22 (2), 328-333, 2015 | 52 | 2015 |
| Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease JJ Gaare, GS Nido, P Sztromwasser, PM Knappskog, O Dahl, ... Movement Disorders 33 (10), 1591-1600, 2018 | 49 | 2018 |
| Autonomic symptoms and dopaminergic treatment in de novo Parkinson's disease B Müller, J Assmus, JP Larsen, K Haugarvoll, GO Skeie, OB Tysnes, ... Acta Neurologica Scandinavica 127 (4), 290-294, 2013 | 49 | 2013 |
Charalampos TzoulisUniversity of BergenVerified email at uib.no
